Who Paid My Doc
Robert Sidbury
Pediatric Dermatology Seattle, WA Medical Doctor
NPI 1861507113 CMS profile 265829
4800 Sand Point Way Ne, Seattle Children's Hospital A7916, Seattle, WA 98105
General payments
$48,550
Research payments
$22,691
Ownership & investment interest
$0
Research they led as principal investigator
$500,963
Through program year 2025, Robert Sidbury of Seattle, WA is reported in the CMS Open Payments database as having received $48,550 across 33 general payments and $22,691 in research payments paid to them. Separately, studies naming them as principal investigator received $500,963 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 91st percentile of Pediatric Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
12 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $192 | 2 | |
| 2024 | General | $9,195 | 9 | |
| 2024 | Research | $2,328 | 1 | |
| 2023 | General | $11,525 | 11 | |
| 2023 | Research | $2,736 | 3 | |
| 2022 | General | $11,724 | 3 | |
| 2022 | Research | $7,233 | 18 | |
| 2021 | General | $7,280 | 2 | |
| 2021 | Research | $4,739 | 4 | |
| 2020 | General | $1,200 | 1 | |
| 2020 | Research | $5,656 | 5 | |
| 2019 | General | $7,433 | 5 |
Beside peers
- Robert Sidbury
- Pediatric Dermatology median
- Middle half of Pediatric Dermatology
- National median
In program year 2025, general payments to Robert Sidbury were reported at $192. Among 172 Pediatric Dermatology profiles paid that year, the median was $302 and the middle half received between $110 and $2,128.
Show as a table
| Year | Robert Sidbury | Pediatric Dermatology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $7,433 | $280 | $89–$1,853 | $163 |
| 2020 | $1,200 | $263 | $71–$2,376 | $114 |
| 2021 | $7,280 | $227 | $69–$1,800 | $132 |
| 2022 | $11,724 | $289 | $69–$1,516 | $149 |
| 2023 | $11,525 | $537 | $114–$3,255 | $160 |
| 2024 | $9,195 | $437 | $114–$2,693 | $164 |
| 2025 | $192 | $302 | $110–$2,128 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
64 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Dermatology in Washington
Ross Brockman
Pediatric Dermatology · Puyallup, WA
Sharon Kelly
Pediatric Dermatology · Bellevue, WA
Deepti Gupta
Pediatric Dermatology · Seattle, WA
Julie Francis
Pediatric Dermatology · Bellevue, WA
Heather Brandling Bennett
Pediatric Dermatology · Seattle, WA
Kathryn Erickson
Pediatric Dermatology · Bellevue, WA
Related records
Pediatric Dermatology in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Dermatology
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.